ESC 365 - Aspirin after stenting - Do we still need it?

Back

ESC Premium Access

Aspirin after stenting - Do we still need it?

Session: Safer stents and strategies: is it time for the de-escalation of dual antiplatelet treatment regimes?

Topic: Stents

Speaker: Professor G. Montalescot (Paris, FR)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Professor Gilles Montalescot

Pitie Salpetriere APHP University Hospital, Paris (France)

32 presentations

1 follower

3 more presentations in this session

De-escalation of dual antiplatelet therapy intensity in acute coronary syndrome.

Speaker: Professor S. Schuepke (Munich, DE)

Access

Slides

Video

Stent type and duration of dual antiplatelet therapy.

Speaker: Professor T. Kimura (Hirakata, JP)

Access

Slides

Video

De-escalation antithrombotic therapy in stented patients with atrial fibrillation.

Speaker: Professor D. Angiolillo (Jacksonville, US)

Access

Slides

Video

Access the full session

Safer stents and strategies: is it time for the de-escalation of dual antiplatelet treatment regimes?

Speakers: Professor G. Montalescot, Professor S. Schuepke, Professor T. Kimura, Professor D. Angiolillo

Access

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

Aspirin after stenting - Do we still need it?

About the speaker

Professor Gilles Montalescot

3 more presentations in this session

De-escalation of dual antiplatelet therapy intensity in acute coronary syndrome.

Stent type and duration of dual antiplatelet therapy.

De-escalation antithrombotic therapy in stented patients with atrial fibrillation.

Access the full session

Safer stents and strategies: is it time for the de-escalation of dual antiplatelet treatment regimes?

About the event

ESC Congress 2018

ESC 365 is supported by